Treating patients with non-STEMI: Stent the culprit artery only or address all lesions?

Current Treatment Options in Cardiovascular Medicine

Volumn 10, Issue 1, 2008, Pages 93-97

  Shishehbor, Mehdi H ^b   Bhatt, Deepak L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DRUG ELUTING STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; RISK BENEFIT ANALYSIS; THERMOGRAPHY; UNSTABLE ANGINA PECTORIS;

EID: 39049126253     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-008-0010-4     Document Type: Review

References (27)

1. Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002, 106:1893-1900.
2. Silber S, Albertsson P, Aviles FF, et al.: Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005, 26:804-847.
3. Bhatt DL: Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events. J Invasive Cardiol 2003, 15(Suppl B):3B-9B; discussion 9B-10B.
4. Bhatt DL: To cath or not to cath: that is no longer the question. JAMA 2005, 293:2935-2937.
5. Fuster V, Moreno PR, Fayad ZA, et al.: Atherothrombosis and high-risk plaque part I: evolving concepts. J Am Coll Cardiol 2005, 46:937-954.
6. Bhatt DL: Embolization - a pathological mechanism in renal artery stenosis. J Invasive Cardiol 2004, 16:196-197.
7. Shishehbor MH, Topol EJ, Mukherjee D, et al.: Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol 2006, 97:1585-1590.
8. Bhatt DL, Topol EJ: Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 2005, 112:906-915; discussion 923.
9. Buffon A, Biasucci LM, Liuzzo G, et al.: Widespread coronary inflammation in unstable angina. N Engl J Med 2002, 347:5-12.
10. Kornowski R, Mehran R, Satler LF, et al.: Procedural results and late clinical outcomes following multivessel coronary stenting. J Am Coll Cardiol 1999, 33:420-426.
11. Moussa I, Reimers B, Moses J, et al.: Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. Circulation 1997, 96:3873-3879.
12. Shishehbor MH, Lauer MS, Singh IM, et al.: In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol 2007, 49:849-854.
13. Brener SJ, Murphy SA, Gibson CM, et al.: Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. Am J Cardiol 2002, 90:631-633.
14. Hlatky MA, Rogers WJ, Johnstone I, et al.: Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1997, 336:92-99.
15. Ijsselmuiden AJ, Ezechiels J, Westendorp IC, et al.: Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 2004, 148:467-474.
16. Kim SW, Hong MK, Lee CW, et al.: Multivessel coronary stenting versus bypass surgery in patients with multivessel coronary artery disease and normal left ventricular function: immediate and 2-year long-term follow-up. Am Heart J 2000, 139:638-642.
17. Bavry AA, Kumbhani DJ, Helton TJ, et al.: Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006, 119:1056-1061.
18. Bavry AA, Bhatt DL: Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint? Am Heart J 2007, 153:719-721.
19. Rabbat MG, Bavry AA, Bhatt DL, Ellis SG: Understanding and minimizing late thrombosis of drug-eluting stents. Cleve Clin J Med 2007, 74:129-136.
20. Rioufol G, Finet G, Ginon I, et al.: Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002, 106:804-808.
21. Kelly P, Bhatt DL: Identification of vulnerable plaque - the quest continues. J Invasive Cardiol 2007, 19:55-57.
22. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993, 341:573-580.
23. CABRI Trial Participants: First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 1995, 346:1179-1184.
24. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996, 335:217-225.
25. The EPISTENT Investigators: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glyco-protein-IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998, 352:87-92.
26. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000, 35:1122-1129.
27. Glaser R, Selzer F, Faxon DP, et al.: Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 2005, 111:143-149.